Mar 10, 2022 | In the News
Virginia Economic Review SOURCE Virginia Economic Development Partnership Virginia Economic Review “This issue of Virginia Economic Review explores the life sciences industry in Virginia, including public and private research and development, medical...
Mar 10, 2022 | In the News
A Supply Chain Reaction SOURCE Virginia Economic Review A Supply Chain Reaction “Richmond and Petersburg host a new pharmaceutical cluster making essential medicines with innovative techniques.” Read...
Mar 4, 2022 | In the News
Civica to Manufacture Affordable Insulins at its Plant in Peterburg SOURCE The Progress-Index Civica to Manufacture Affordable Insulins at its Plant in Petersburg “Civica Inc. to use its Petersburg plant for manufacturing a new affordable line of...
Mar 3, 2022 | In the News
Civica Plans to Provide Insulin at No More than $30 per Vial SOURCE BioSpace by Mark Terry “The organization announced its intentions to manufacture and distribute insulins that will be available to individuals with diabetes at lower prices than those presently...
Mar 3, 2022 | In the News
Non-Profit Drug Maker Will Provide Insulin for No More Than $30 a Vial SOURCE CNN Politics by Tami Luhby Non-profit drug maker will provide insulin for no more than $30 a vial “Civica Rx, a non-profit generic drug maker backed by hospitals, insurers and...
Mar 2, 2022 | In the News
Pharma Cluster to Produce Regional Economic Development and Revitalization SOURCE Virginia’s Gateway Region Image by Phlow™ Pharma Cluster to Produce Regional Economic Development and Revitalization “While AMPAC Fine Chemicals, alone, is creating excellent...
